Previous 10 | Next 10 |
Now is a great time to have biotech stocks in your portfolio. While biotech investing can be scary, because the small-cap companies are often unprofitable research-and-development labs, this is also where a lot of the cutting-edge science is happening. Let's see how Mirati Therapeutics (NA...
Biotech Pulse Biotech finally has a pulse. The improving appetite for risk has resuscitated the moribund biotechs and pharma (biopharma) groups. The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have begun their advance from their year-to-date lows recorded earlier in Octo...
Mirati Therapeutics (NASDAQ: MRTX ): Q3 GAAP EPS of -$1.38 misses by $0.13 . More news on: Mirati Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
SAN DIEGO , Nov. 4, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September 30, 2019 . Recent Corporate Updates: Presented early clinical data from the Ph...
Look out, cancer: There could be two new sheriffs in town. Not long ago, Amgen (NASDAQ: AMGN) presented early results from the first clinical trial with easy-to-swallow capsules that fight cancer in a way previously considered impossible. More recently, Mirati Therapeutics (NASDAQ: MRTX) ...
The biotech version of David vs. Goliath just got more interesting, with the $3.7-billion-market-cap Mirati Therapeutics (NASDAQ: MRTX) posting data this week for its KRAS inhibitor MRTX849 suggesting it can be competitive with AMG 510 from Amgen (NASDAQ: AMGN) , which weighs in at a ma...
Shares of Mirati Therapeutics (NASDAQ: MRTX) , a clinical-stage biopharmaceutical company, are rising again today. This time, the stock is soaring in response to highly anticipated clinical trial data produced by Mirati, instead of by a similar program from Amgen (NASDA...
Gainers: Wins Finance Holdings (NASDAQ: WINS ) +49% . Synthesis Energy Systems (NASDAQ: SES ) +36% . Amkor Technology (NASDAQ: AMKR ) +30% . PG&E (NYSE: PCG ) +20% . Texas Roadhouse (NASDAQ: TXRH ) +19% . Talos Energy (NYSE: TALO ) +16% . Harmonic (NASDAQ: HLIT ) +15% . Na...
Amkor Technology (NASDAQ: AMKR ) +16% on Q3 results . More news on: Amkor Technology, Inc., Mirati Therapeutics, Inc., Globus Maritime Limited, Stocks on the move, Read more ...
Mirati Therapeutics (NASDAQ: MRTX ) is up 22.2% after hours following results from its Phase 1/2 trial of MRTX849 . More news on: Mirati Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Mirati Therapeutics Inc. Company Name:
MRTX Stock Symbol:
NASDAQ Market:
Mirati Therapeutics Inc. Website:
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation PR Newswire SAN DIEGO and ZUG, Switzerland , Jan. 10, 2024 /PRNewswire/ -- Mirati The...
2023-12-18 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...